Gamida Cell EBITDA vs. Price To Sales

GMDADelisted Stock  USD 1.40  0.09  6.04%   
Taking into consideration Gamida Cell's profitability measurements, Gamida Cell may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Gamida Cell's ability to earn profits and add value for shareholders.
For Gamida Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gamida Cell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gamida Cell utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gamida Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gamida Cell over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Please note, there is a significant difference between Gamida Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gamida Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gamida Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Gamida Cell Price To Sales vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Gamida Cell's current stock value. Our valuation model uses many indicators to compare Gamida Cell value to that of its competitors to determine the firm's financial worth.
Gamida Cell is rated # 4 in ebitda category among its peers. It is rated below average in price to sales category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gamida Cell's earnings, one of the primary drivers of an investment's value.

Gamida Price To Sales vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Gamida Cell

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(70.62 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Gamida Cell

P/S

 = 

MV Per Share

Revenue Per Share

 = 
6.44 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Gamida Price To Sales Comparison

Gamida Cell is currently under evaluation in price to sales category among its peers.

Gamida Cell Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Gamida Cell, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gamida Cell will eventually generate negative long term returns. The profitability progress is the general direction of Gamida Cell's change in net profit over the period of time. It can combine multiple indicators of Gamida Cell, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company was founded in 1998 and is headquartered in Jerusalem, Israel. Gamida Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 166 people.

Gamida Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Gamida Cell. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gamida Cell position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gamida Cell's important profitability drivers and their relationship over time.

Use Gamida Cell in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gamida Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamida Cell will appreciate offsetting losses from the drop in the long position's value.

Gamida Cell Pair Trading

Gamida Cell Pair Trading Analysis

The ability to find closely correlated positions to Gamida Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gamida Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gamida Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gamida Cell to buy it.
The correlation of Gamida Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gamida Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gamida Cell moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gamida Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Gamida Cell position

In addition to having Gamida Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corporate Bonds Funds Thematic Idea Now

Corporate Bonds Funds
Corporate Bonds Funds Theme
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Gamida Stock

If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format